Claudiani, S., Apperley, J. F., Gale, R. P., Clark, R., Szydlo, R., Deplano, S., . . . Milojkovic, D. (2017). E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy. Haematologica.
Chicago Stili AlıntıClaudiani, Simone, et al. "E14a2 BCR-ABL1 Transcript Is Associated With a Higher Rate of Treatment-free Remission in Individuals With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitor Therapy." Haematologica 2017.
MLA AlıntıClaudiani, Simone, et al. "E14a2 BCR-ABL1 Transcript Is Associated With a Higher Rate of Treatment-free Remission in Individuals With Chronic Myeloid Leukemia After Stopping Tyrosine Kinase Inhibitor Therapy." Haematologica 2017.